MX2019010229A - Composicion para la liberacion controlada de sustancias fisiologicamente activas y proceso para su preparacion. - Google Patents

Composicion para la liberacion controlada de sustancias fisiologicamente activas y proceso para su preparacion.

Info

Publication number
MX2019010229A
MX2019010229A MX2019010229A MX2019010229A MX2019010229A MX 2019010229 A MX2019010229 A MX 2019010229A MX 2019010229 A MX2019010229 A MX 2019010229A MX 2019010229 A MX2019010229 A MX 2019010229A MX 2019010229 A MX2019010229 A MX 2019010229A
Authority
MX
Mexico
Prior art keywords
composition
preparation
controlled release
active substances
physiologically active
Prior art date
Application number
MX2019010229A
Other languages
English (en)
Inventor
Gaspari Enrico
farnedi Flavio
Ungheri Devis
Valentini Arnaldo
Original Assignee
Bioscreen Tech S R L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioscreen Tech S R L filed Critical Bioscreen Tech S R L
Publication of MX2019010229A publication Critical patent/MX2019010229A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K40/00—Shaping or working-up of animal feeding-stuffs
    • A23K40/30—Shaping or working-up of animal feeding-stuffs by encapsulating; by coating
    • A23K40/35—Making capsules specially adapted for ruminants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5089—Processes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Polymers & Plastics (AREA)
  • Zoology (AREA)
  • Food Science & Technology (AREA)
  • Fodder In General (AREA)
  • Analysing Materials By The Use Of Radiation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invención se refiere a una composición resistente al rumen en forma de microgránulos, un proceso para su producción y un alimento que contiene dicha composición.
MX2019010229A 2017-02-27 2018-02-26 Composicion para la liberacion controlada de sustancias fisiologicamente activas y proceso para su preparacion. MX2019010229A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT102017000021852A IT201700021852A1 (it) 2017-02-27 2017-02-27 Composizione a rilascio controllato di sostanze fisiologicamente attive e processo per la sua preparazione
PCT/IB2018/051189 WO2018154531A1 (en) 2017-02-27 2018-02-26 Composition for controlled release of physiologically active substances and process for its preparation

Publications (1)

Publication Number Publication Date
MX2019010229A true MX2019010229A (es) 2019-12-19

Family

ID=59579808

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2019010229A MX2019010229A (es) 2017-02-27 2018-02-26 Composicion para la liberacion controlada de sustancias fisiologicamente activas y proceso para su preparacion.
MX2022013576A MX2022013576A (es) 2017-02-27 2019-08-27 Composicion para la liberacion controlada de sustancias fisiologicamente activas y proceso para su preparacion.

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2022013576A MX2022013576A (es) 2017-02-27 2019-08-27 Composicion para la liberacion controlada de sustancias fisiologicamente activas y proceso para su preparacion.

Country Status (9)

Country Link
US (2) US20220175684A2 (es)
EP (1) EP3585362A1 (es)
JP (1) JP7273735B2 (es)
CN (1) CN110582273A (es)
BR (1) BR112019017823A2 (es)
CA (1) CA3054772A1 (es)
IT (1) IT201700021852A1 (es)
MX (2) MX2019010229A (es)
WO (1) WO2018154531A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3139731A1 (en) * 2019-06-14 2020-12-17 Takehiro Nishikawa Delayed disintegration-type capsule and method for producing same

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0829052B2 (ja) * 1987-06-19 1996-03-27 日本曹達株式会社 反芻動物用飼料添加物
NO920067L (no) * 1991-01-14 1992-07-15 Ajinomoto Kk Foradditiv for droevtyggere
JP2929812B2 (ja) * 1991-01-14 1999-08-03 味の素株式会社 反すう動物用飼料添加組成物
JPH05192096A (ja) * 1991-11-07 1993-08-03 Ajinomoto Co Inc 反すう動物用飼料添加組成物
US5429832A (en) * 1991-11-07 1995-07-04 Ajinomoto Co., Inc. Feed additive composition for ruminants
ITMI20041820A1 (it) 2004-09-24 2004-12-24 Ascor Chimici Srl Composizione in micro-pellets a rilascio controllato di sostanze fisiologicamente attive, procedimento di preparazione e relativo impiego nel settore zootecnico.
FR2879074B1 (fr) * 2004-12-15 2007-08-03 Adisseo France Sas Soc Par Act Granules de principe actif hydrophile
ITMI20061583A1 (it) * 2006-08-04 2008-02-05 Eurhema S R L Composizioni di microparticelle e granuli per il rilascio controllato orale di sostanze per uso veterinario
WO2010122583A2 (en) * 2009-04-24 2010-10-28 Rubicon Research Private Limited Oral pharmaceutical compositions of acid labile substances
US11110057B2 (en) * 2010-04-07 2021-09-07 Kemin Industries, Inc. Micro particles for oral delivery in animals
CN102946872A (zh) * 2010-05-03 2013-02-27 阿普塔利斯制药有限公司 包含含有胰酶的消化酶混合物的微丸组合物
CN103168923A (zh) * 2012-01-16 2013-06-26 北京伟嘉人生物技术有限公司 一种饲用肠溶微囊化复合氨基酸添加剂及其制备方法
MX369410B (es) * 2014-01-31 2019-11-07 Morishita Jintan Co Agente de administración oral para rumiantes y alimento para rumiantes que lo contiene.
US20150272167A1 (en) * 2014-03-27 2015-10-01 Purina Animal Nutrition Llc Additive for ruminant feed
CN106659196A (zh) * 2014-08-20 2017-05-10 拜内梅尔克公司 用于泌乳反刍动物的包衣饲料组合物及制备和使用该饲料组合物的方法
CN104970228A (zh) * 2015-06-16 2015-10-14 浙江万方生物科技有限公司 一种过瘤胃赖氨酸的制备方法

Also Published As

Publication number Publication date
CN110582273A (zh) 2019-12-17
WO2018154531A1 (en) 2018-08-30
US20240165042A1 (en) 2024-05-23
EP3585362A1 (en) 2020-01-01
JP2020508354A (ja) 2020-03-19
IT201700021852A1 (it) 2018-08-27
MX2022013576A (es) 2022-11-30
BR112019017823A2 (pt) 2020-03-31
US20220175684A2 (en) 2022-06-09
US20200060978A1 (en) 2020-02-27
CA3054772A1 (en) 2018-08-30
JP7273735B2 (ja) 2023-05-15
US20210077414A9 (en) 2021-03-18

Similar Documents

Publication Publication Date Title
PH12020550849A1 (en) Spray-dried mixture of human milk oligosaccharides
MX2019010228A (es) Composición para liberación controlada de sustancias fisiológicamente activas y proceso para su preparación.
MX2018002627A (es) Metodo de cristalizacion y biodisponibilidad.
MX2019015744A (es) Composiciones farmaceuticas.
WO2015104658A3 (en) Amorphous solid dispersion of dapagliflozin and process for the preparation of amorphous dapagliflozin
MX2020002123A (es) Sales de ribociclib y formas en estado sólido de las mismas.
MX2018000743A (es) Granulos de manitol para compresion directa.
PH12020550125A1 (en) Crystalline forms of 3-substituted 1,2,4-oxadiazole
MX2017009289A (es) Formulaciones farmaceuticas que comprenden cangrelor de alta pureza y metodos para preparar y utilizar las mismas.
PH12016502544B1 (en) Pharmaceutical preparation containing entecavir as active ingredient, and preparation method therefor
MX2017006513A (es) Compuestos de tipo 1,9-diazaespiroundecano con actividad multimodal contra el dolor.
MX2020009447A (es) Proceso para la produccion de una composicion alimenticia con capacidad de flujo mejorada.
EP3311817A4 (en) PHARMACEUTICAL COMPOSITION FOR THE PREVENTION AND TREATMENT OF EYES DISEASES WITH IMATINIB AS AN ACTIVE SUBSTANCE
MX2022013576A (es) Composicion para la liberacion controlada de sustancias fisiologicamente activas y proceso para su preparacion.
PH12016501205B1 (en) Catecholamine production accelerator, and therapeutic and preventive agent and therapeutic and preventive food composition for diseases caused by catecholamine deficiency
PH12019500024A1 (en) Pharmaceutical compositions
WO2015095659A3 (en) Indirubin solid dispersion composition
EP3600366A4 (en) PROCESS FOR THE PREPARATION OF PROBIOTIC POWDER FORMULATIONS FOR MONOGASTRIC ANIMALS
MX2019011270A (es) Productos masticables en gel para ingredientes farmaceuticos activos.
PH12017500323A1 (en) P38 map kinase inhibiting indanyl urea compounds
MY186185A (en) Encapsulated fillings
MX2019015869A (es) Nuevas formulaciones orales de belinostat.
WO2019078646A3 (ko) 콩 배양조직 추출물을 포함하는 탈모방지 또는 육모촉진용 조성물 및 이의 제조방법
PH12019550098A1 (en) Nutritional composition in powder form provided in single serving capsules
WO2014122671A3 (en) Solid oral compositions of saxagliptin